Literature DB >> 3006435

Effects of repeated mammographic screening on breast cancer stage distribution. Results from a randomised study of 92 934 women in a Swedish county.

G Fagerberg, L Baldetorp, O Gröntoft, B Lundström, J C Månson, B Nordenskjöld.   

Abstract

A randomised controlled trial of mass screening for breast cancer by single-view mammography was begun in Sweden in 1977. All women aged 40 and older and resident in the counties of Kopparberg and Ostergötland were enrolled. The present report is confined to the Ostergötland study, which started in 1978 and comprised 92 934 women. After randomisation, which was done on the basis of communities rather than individuals, 47 001 women were allocated to the study group and offered repeated mammographic screening; 45 933 were allocated to the control group. As compliance among women over 74 years of age was poor these were excluded from the present report. The yearly incidence of stage II or more advanced breast cancers after the initial screening round up to and including the second was reduced by 40 per cent in the study group compared with the controls. This effect was less marked in the age group 40-49. After 5.5 years average from the date of entry the absolute number of women with stage II-IV disease in the control group exceeded that for the study group by 44, whereas there was a large excess of cancer in situ and stage I cancer in the study group.

Entities:  

Mesh:

Year:  1985        PMID: 3006435     DOI: 10.3109/02841868509134418

Source DB:  PubMed          Journal:  Acta Radiol Oncol        ISSN: 0349-652X


  19 in total

Review 1.  Preventive health care, 2001 update: screening mammography among women aged 40-49 years at average risk of breast cancer.

Authors:  J Ringash
Journal:  CMAJ       Date:  2001-02-20       Impact factor: 8.262

Review 2.  Aneuploidy as a prognostic factor in breast cancer.

Authors:  A von Rosen
Journal:  Med Oncol Tumor Pharmacother       Date:  1989

3.  Cytometric and histopathologic features of tumors detected in a randomized mammography screening program: correlation and relative prognostic influence.

Authors:  T Hatschek; O Gröntoft; G Fagerberg; O Stål; S Sullivan; J Carstensen; B Nordenskjöld
Journal:  Breast Cancer Res Treat       Date:  1990-05       Impact factor: 4.872

4.  Canadian National Breast Screening Study.

Authors:  J J Caro; J A O'Brien; S C Hartz
Journal:  CMAJ       Date:  1993-03-15       Impact factor: 8.262

5.  Influence of S-phase fraction on metastatic pattern and post-recurrence survival in a randomized mammography screening trial.

Authors:  T Hatschek; J Carstensen; G Fagerberg; O Stål; O Gröntoft; B Nordenskjöld
Journal:  Breast Cancer Res Treat       Date:  1989-12       Impact factor: 4.872

6.  Prognostic value of nuclear DNA content in breast cancer in relation to tumor size, nodal status, and estrogen receptor content.

Authors:  A von Rosen; L E Rutqvist; J Carstensen; A Fallenius; L Skoog; G Auer
Journal:  Breast Cancer Res Treat       Date:  1989-01       Impact factor: 4.872

7.  The Stockholm breast cancer screening trial--5-year results and stage at discovery.

Authors:  J Frisell; G Eklund; L Hellström; U Glas; A Somell
Journal:  Breast Cancer Res Treat       Date:  1989-01       Impact factor: 4.872

8.  The Swedish two county trial of mammographic screening for breast cancer: recent results and calculation of benefit.

Authors:  L Tabar; G Fagerberg; S W Duffy; N E Day
Journal:  J Epidemiol Community Health       Date:  1989-06       Impact factor: 3.710

Review 9.  [Radiological diagnosis of mammary carcinomas. I: pathology and x-ray mammography].

Authors:  R Schulz-Wendtland; H-P Sinn
Journal:  Radiologe       Date:  2004-05       Impact factor: 0.635

10.  Randomized study of mammography screening--preliminary report on mortality in the Stockholm trial.

Authors:  J Frisell; G Eklund; L Hellström; E Lidbrink; L E Rutqvist; A Somell
Journal:  Breast Cancer Res Treat       Date:  1991-03       Impact factor: 4.872

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.